Martha R. Charney

Pegunigalsidase alfa, a novel PEGylated enzyme replacement therapy for Fabry disease, provides sustained plasma concentrations and favorable pharmacodynamics: A 1‐year Phase 1/2 clinical trial

Raphael Schiffmann, Özlem Göker-Alpan, Myrl Holida et al. · Journal of Inherited Metabolic Disease · 2019 · 133 citations · Full text

Tolerability, Gut Effects, and Pharmacokinetics of Methylnaltrexone Following Repeated Intravenous Administration in Humans

Chun‐Su Yuan, Harold D. Doshan, Martha R. Charney et al. · The Journal of Clinical Pharmacology · 2005 · 85 citations

Opioid Epidemic, Steady State, Healthy Subjects +13

5% Amlexanox oral paste, a new treatment for recurrent minor aphthous ulcers

Atul Khandwala, R.G. Van Inwegen, Martha R. Charney et al. · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · 1997 · 43 citations

Gastroenterology, Surgery, Dermatology +2

Effects of Application Durations and Heat on the Pharmacokinetic Properties of Drug Delivered by a Lidocaine/Tetracaine Patch: A Randomized, Open-Label, Controlled Study in Healthy Volunteers

Thomas B. Marriott, Martha R. Charney, Stephanie H. Stanworth · Clinical Therapeutics · 2012 · 18 citations

Drug Delivered, Medicine, Local Pharmacology +6